Power Law company profile

Sinocare

Biotech & Life Sciences · Changsha, China · Founded 2002 · IPO 2012 Unicorn

Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing

Valuation

$1.27B

Market cap · May/2026

Revenue

$641M

Latest reported FY

EBITDA

$87M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Global footprint

Where Sinocare has talent and traffic

Workforce by country

🇨🇳 China · Changsha HQ

Book a demo for the full country breakdown

Patent intelligence

$112M patent portfolio · 104 active families

Estimated portfolio value

$112M

8.8% of market cap · comparable to top peer Tandem Diabetes Care ($109M)

104 active patent families

Where Sinocare innovates Test stripsAnalyteDiagnostic Test ResultElectrodeBiomedical engineering

Where Sinocare concentrates vs peers

Each axis is a top-10 topic across Sinocare and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Sinocare

An AI-synthesized read of the highest-engagement posts about Sinocare on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sinocare on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles